BioNexus Gene Lab Corp's total assets for Q1 2025 were $9.48M, a decrease of -9.14% from the previous quarter. BGLC total liabilities were $1.71M for the fiscal quarter, a -19.08% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.